Obituaries
PGe
PG Store
Archives
Classifieds
Classified
Events
Jobs
Real Estate
Legal Notices
Pets
MENU
SUBSCRIBE
LOGIN
REGISTER
LOG OUT
MY PROFILE
Home
News
Local
Sports
Opinion
A&E
Life
Business
Contact Us
NEWSLETTERS
MENU
ACCOUNT
Subscribe
Login
Register
Log out
My Profile
Subscriber Services
Search
SECTIONS
HOME
Homepage
This Just In
Chats
Weather
Traffic
Event Guide
PG Store
PGe
Video
Photos
The Digs
RSS Feeds
NEWS
News Home
COVID-19
World
Nation
State
Obituaries
News Obituaries
Politics
Education
Portfolio
Science
Health & Wellness
Environment
Aging Edge
Transportation
Faith & Religion
Crimes & Courts
Social Services
LOCAL
Local Home
Region
City
North
East
West
South
Washington
Westmoreland
The Neighborhood
Obituaries
Classifieds
Legal Notices
Real Estate
SPORTS
Sports Home
Steelers
Penguins
Pirates
Sports Columns
Gene Collier
Ron Cook
Joe Starkey
Paul Zeise
High School Sports
College Sports
Pitt
Penn State
WVU
NCAA
NFL
MLB
NBA
NHL
North Shore Drive Podcast
OPINION
Opinion Home
Editorials
Letters
Op-Ed Columns
PG Columnists
Insight
A&E
A&E Home
Celebrities
Movies
TV & Radio
Music
Concert Listings
Theatre & Dance
Art & Architecture
Books
Events
LIFE
Life Home
Food
Buying Here
Homes & Gardens
Style & Fashion
Travel
Restaurants
Seen
goodness
Random Acts of Kindness
Pets
Beer Me
Outdoors
Holidays
BUSINESS
Business Home
Your Money
Wheels
Workzone
Business Health
Tech News
Building PGH
Powersource
Business / Law
Top Workplaces
Business of Pittsburgh
Consumer Alerts
OTHER
PGe
NEWSLETTERS
PG STORE
ARCHIVES
CLASSIFIEDS
OBITUARIES
JOBS
LEGAL NOTICES
REAL ESTATE
CLASSIFIEDS
EVENTS
PETS
CONTACT US / FAQ
CONTACT US
ADVERTISING
CAREER OPPORTUNITIES
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Fennec Pharmaceuticals Inc. - Common Stock
(NQ:
FENC
)
7.515
-0.055 (-0.73%)
Streaming Delayed Price
Updated: 10:05 AM EST, Dec 4, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Fennec Pharmaceuticals Inc. - Common Stock
< Previous
1
2
Next >
Fennec Q2 Sales Jump 33 Percent
↗
August 14, 2025
Via
The Motley Fool
Fennec (FENC) Q2 2025 Earnings Call Transcript
↗
August 14, 2025
Via
The Motley Fool
Topics
Earnings
Intellectual Property
Fennec Pharmaceuticals Inc (NASDAQ:FENC) Reports Mixed Q2 2025 Earnings with Revenue Slight Miss and Wider-Than-Expected Loss
↗
August 14, 2025
Fennec Pharmaceuticals reported mixed Q2 2025 results, missing revenue estimates by 0.6% and posting a wider EPS loss. PEDMARK® growth and new accounts drove optimism despite financial...
Via
Chartmill
Earnings Scheduled For August 14, 2025
↗
August 14, 2025
Via
Benzinga
Fennec Pharmaceuticals Earnings Preview
↗
August 13, 2025
Via
Benzinga
Nasdaq, S&P 500 Hit 6-Month Lows As Recession Fears Grow: What's Driving Markets Monday?
↗
March 10, 2025
Stocks extended last week's losses on Monday as concerns over the U.S. economy continue to weigh on the market. The Nasdaq 100 saw the steepest declines, with Tesla, Inc. (NASDAQ:TSLA) and Palantir...
Via
Benzinga
Topics
Economy
Stocks
Fennec Pharmaceuticals's Earnings Outlook
↗
March 20, 2024
Via
Benzinga
Earnings Scheduled For May 13, 2025
↗
May 13, 2025
Via
Benzinga
Earnings Scheduled For March 10, 2025
↗
March 10, 2025
Via
Benzinga
Why BP Shares Are Trading Higher By 6%; Here Are 20 Stocks Moving Premarket
↗
February 10, 2025
Via
Benzinga
FENC Stock Earnings: Fennec Pharmaceuticals Misses EPS, Misses Revenue for Q2 2024
↗
August 13, 2024
FENC stock results show that Fennec Pharmaceuticals missed analyst estimates for earnings per share and missed on revenue for the second quarter of 2024.
Via
InvestorPlace
Earnings Scheduled For November 6, 2023
↗
November 06, 2023
Companies Reporting Before The Bell • Kosmos Energy (NYSE:KOS) is expected to report quarterly earnings at $0.16 per share on revenue of $366.82 million.
Via
Benzinga
Preview: Fennec Pharmaceuticals's Earnings
↗
November 03, 2023
Via
Benzinga
Analyst Ratings for Fennec Pharmaceuticals
↗
June 21, 2023
Via
Benzinga
Recap: Fennec Pharmaceuticals Q1 Earnings
↗
May 11, 2023
Via
Benzinga
3 Dirt-Cheap Stocks Under $10 That Could EXPLODE!
↗
July 29, 2024
These dirt cheap stocks under $10 have the potential to rise rapidly and create fortunes for bold investors.
Via
InvestorPlace
Why Alibaba Shares Are Trading Lower By Around 7%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
↗
May 14, 2024
Via
Benzinga
FENC Stock Earnings: Fennec Pharmaceuticals Beats EPS, Beats Revenue for Q1 2024
↗
May 14, 2024
FENC stock results show that Fennec Pharmaceuticals beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024.
Via
InvestorPlace
Earnings Outlook For Fennec Pharmaceuticals
↗
May 10, 2023
Via
Benzinga
Analyst Ratings for Fennec Pharmaceuticals
↗
April 06, 2023
Via
Benzinga
Expert Ratings for Fennec Pharmaceuticals
↗
November 22, 2022
Via
Benzinga
What 4 Analyst Ratings Have To Say About Fennec Pharmaceuticals
↗
November 22, 2022
Via
Benzinga
FENC Stock Earnings: Fennec Pharmaceuticals Misses EPS, Beats Revenue for Q4 2023
↗
March 21, 2024
FENC stock results show that Fennec Pharmaceuticals missed analyst estimates for earnings per share but beat on revenue for the fourth quarter of 2023.
Via
InvestorPlace
Earnings Scheduled For March 21, 2024
↗
March 21, 2024
Companies Reporting Before The Bell • Creative Realities (NASDAQ:CREX) is expected to report quarterly earnings at $0.02 per share on revenue of $16.47 million.
Via
Benzinga
4 Analysts Have This to Say About Fennec Pharmaceuticals
↗
November 22, 2022
Via
Benzinga
Where Fennec Pharmaceuticals Stands With Analysts
↗
November 22, 2022
Via
Benzinga
After Two FDA Rejections, Fennec Pharma Lead Drug Scores US Approval For Chemo-Induced Hearing Loss
↗
September 21, 2022
Via
Benzinga
7 Biotech Stocks Sitting in the Sweet Spot
↗
March 24, 2023
Biotech stocks have the potential for massive profits if their companies are successful in developing drugs that are safe and marketable.
Via
InvestorPlace
US Stocks Open Lower; Dow Dips 250 Points
↗
January 25, 2023
U.S. stocks traded lower this morning, with the Dow Jones dropping around 250 points on Wednesday. Following the market opening Wednesday, the Dow traded down 0.74% to 33,484.47 while the NASDAQ fell...
Via
Benzinga
Why Stabilis Solutions Shares Jumped Over 71%; Here Are 70 Biggest Movers From Yesterday
↗
September 22, 2022
Gainers
Via
Benzinga
< Previous
1
2
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
TOP
Email a Story
Your e-mail:
Friends e-mail:
Submit
